Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded Study to Examine the Use of N-Acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

NCT02206152 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02206152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded Study to Examine the Use of N-Acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
Lead sponsor
University of Minnesota
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2015
Completion date
December 31, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycemia unawareness, type 1 diabetes